We also developed a predictive nomogram with the combination of B4GALNT1 levels and TNM staging (Fig. 2i and j), and validated its efficiency on discriminating the risk of HCC patients (Fig. 2k). This evidence concerns the gene B4GALNT1 and hepatocellular carcinoma.